News
A new oral GLP-1 drug candidate could transform the diabetes and weight loss drug boom. Why it matters: Eli Lilly said on ...
A new weight-loss pill taken daily could compete with injections like Ozempic, new research suggests. Patients, who all were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results